{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:59:27Z","timestamp":1792191567817,"version":"4.4.0"},"reference-count":40,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2015,8,14]],"date-time":"2015-08-14T00:00:00Z","timestamp":1439510400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0135692","type":"journal-article","created":{"date-parts":[[2015,8,14]],"date-time":"2015-08-14T18:20:51Z","timestamp":1439576451000},"page":"e0135692","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":105,"title":["Comparative Efficacy and Safety of Different Antiplatelet Agents for Prevention of Major Cardiovascular Events and Leg Amputations in Patients with Peripheral Arterial Disease: A Systematic Review and Network Meta-Analysis"],"prefix":"10.1371","volume":"10","author":[{"given":"Konstantinos","family":"Katsanos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavros","family":"Spiliopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Diamantopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narayan","family":"Karunanithy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miltiadis","family":"Krokidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bijan","family":"Modarai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitris","family":"Karnabatidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,8,14]]},"reference":[{"issue":"9901","key":"ref1","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","article-title":"Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis","volume":"382","author":"FG Fowkes","year":"2013","journal-title":"Lancet"},{"issue":"6","key":"ref2","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1056\/NEJM199202063260605","article-title":"Mortality over a period of 10 years in patients with peripheral arterial disease","volume":"326","author":"MH Criqui","year":"1992","journal-title":"The New England journal of medicine"},{"issue":"21","key":"ref3","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.jacc.2008.07.060","article-title":"Progression of peripheral arterial disease predicts cardiovascular disease morbidity and mortality","volume":"52","author":"MH Criqui","year":"2008","journal-title":"Journal of the American College of Cardiology"},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/s00270-014-0876-3","article-title":"Standards of practice for superficial femoral and popliteal artery angioplasty and stenting","volume":"37","author":"K Katsanos","year":"2014","journal-title":"Cardiovascular and interventional radiology"},{"key":"ref5","article-title":"Clinical Guideline 147: Lower Limb Peripheral Arterial Disease: Diagnosis and Management","year":"2012"},{"issue":"Suppl 1","key":"ref6","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ejvs.2006.09.024","article-title":"Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)","volume":"33","author":"L Norgren","year":"2007","journal-title":"European journal of vascular and endovascular surgery: the official journal of the European Society for Vascular Surgery"},{"issue":"5","key":"ref7","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1016\/j.jvs.2011.09.001","article-title":"2011 ACCF\/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society for Vascular Medicine, and Society for Vascular Surgery","volume":"54","author":"TW Rooke","year":"2011","journal-title":"Journal of vascular surgery"},{"issue":"22","key":"ref8","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1093\/eurheartj\/ehr211","article-title":"ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC)","volume":"32","author":"M Tendera","year":"2011","journal-title":"European heart journal"},{"issue":"7329","key":"ref9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"issue":"18","key":"ref10","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1001\/jama.2009.623","article-title":"Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials","volume":"301","author":"JS Berger","year":"2009","journal-title":"JAMA: the journal of the American Medical Association"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.1365-2125.2011.03999.x","article-title":"Anti-platelet therapy: ADP receptor antagonists","volume":"72","author":"YD Wijeyeratne","year":"2011","journal-title":"British journal of clinical pharmacology"},{"issue":"12","key":"ref12","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/S0002-9149(02)02869-2","article-title":"Meta-analysis of results from eight randomized, placebo-controlled trials on the effect of cilostazol on patients with intermittent claudication","volume":"90","author":"PD Thompson","year":"2002","journal-title":"The American journal of cardiology"},{"issue":"20","key":"ref13","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.ehj.2004.07.013","article-title":"Picotamide, a combined inhibitor of thromboxane A2 synthase and receptor, reduces 2-year mortality in diabetics with peripheral arterial disease: the DAVID study","volume":"25","author":"Serneri GG Neri","year":"2004","journal-title":"European heart journal"},{"issue":"14","key":"ref14","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1161\/CIRCULATIONAHA.112.000679","article-title":"Vorapaxar in patients with peripheral artery disease: results from TRA2{degrees}P-TIMI 50","volume":"127","author":"MP Bonaca","year":"2013","journal-title":"Circulation"},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jvs.2014.01.041","article-title":"Bayesian network meta-analysis of nitinol stents, covered stents, drug-eluting stents, and drug-coated balloons in the femoropopliteal artery","volume":"59","author":"K Katsanos","year":"2014","journal-title":"Journal of vascular surgery"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"f2914","DOI":"10.1136\/bmj.f2914","article-title":"Demystifying trial networks and network meta-analysis","volume":"346","author":"EJ Mills","year":"2013","journal-title":"BMJ"},{"issue":"9678","key":"ref17","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"C Baigent","year":"2009","journal-title":"Lancet"},{"issue":"6","key":"ref18","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jstrokecerebrovasdis.2009.07.010","article-title":"Stroke prevention by cilostazol in patients with atherothrombosis: meta-analysis of placebo-controlled randomized trials","volume":"18","author":"S Uchiyama","year":"2009","journal-title":"Journal of stroke and cerebrovascular diseases: the official journal of National Stroke Association"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"D Moher","year":"2009","journal-title":"BMJ"},{"issue":"1","key":"ref20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"AR Jadad","year":"1996","journal-title":"Controlled clinical trials"},{"issue":"5","key":"ref21","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1177\/0272989X12458724","article-title":"Evidence synthesis for decision making 2: a generalized linear modeling framework for pairwise and network meta-analysis of randomized controlled trials","volume":"33","author":"S Dias","year":"2013","journal-title":"Medical decision making: an international journal of the Society for Medical Decision Making"},{"issue":"2","key":"ref22","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial","volume":"64","author":"G Salanti","year":"2011","journal-title":"Journal of clinical epidemiology"},{"issue":"5","key":"ref23","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/sim.5539","article-title":"Extending methods for investigating the relationship between treatment effect and baseline risk from pairwise meta-analysis to network meta-analysis","volume":"32","author":"FA Achana","year":"2013","journal-title":"Statistics in medicine"},{"issue":"5","key":"ref24","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1177\/0272989X13485157","article-title":"Evidence synthesis for decision making 3: heterogeneity\u2014subgroups, meta-regression, bias, and bias-adjustment","volume":"33","author":"S Dias","year":"2013","journal-title":"Medical decision making: an international journal of the Society for Medical Decision Making"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1080\/10618600.1998.10474787","article-title":"General Methods for Monitoring Convergence of Iterative Simulations","volume":"7","author":"SP Brooks","year":"1998","journal-title":"Journal of Computational and Graphical Statistics"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"a1840","DOI":"10.1136\/bmj.a1840","article-title":"The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease","volume":"337","author":"J Belch","year":"2008","journal-title":"BMJ"},{"issue":"9","key":"ref27","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1001\/jama.2010.221","article-title":"Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial","volume":"303","author":"FG Fowkes","year":"2010","journal-title":"JAMA: the journal of the American Medical Association"},{"key":"ref28","first-page":"A14299","article-title":"Cardiovascular Events in Acute Coronary Syndrome Patients With Peripheral Arterial Disease Treated With Ticagrelor Compared to Clopidogrel: Data From the PLATO Trial","volume":"124","author":"MR Patel","year":"2011","journal-title":"Circulation"},{"key":"ref29","article-title":"Cardiovascular events in acute coronary syndrome patients with peripheral arterial disease treated with ticagrelor compared with clopidogrel: Data from the PLATO Trial","author":"MR Patel","year":"2014","journal-title":"European journal of preventive cardiology"},{"issue":"9038","key":"ref30","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)","volume":"348","year":"1996","journal-title":"Lancet"},{"issue":"4","key":"ref31","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jvs.2010.04.027","article-title":"Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial","volume":"52","author":"JJ Belch","year":"2010","journal-title":"Journal of vascular surgery"},{"issue":"9","key":"ref32","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1007\/s00330-012-2441-2","article-title":"Management of peripheral arterial interventions with mono or dual antiplatelet therapy\u2014the MIRROR study: a randomised and double-blinded clinical trial","volume":"22","author":"G Tepe","year":"2012","journal-title":"European radiology"},{"issue":"19","key":"ref33","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.jacc.2007.03.025","article-title":"Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial","volume":"49","author":"DL Bhatt","year":"2007","journal-title":"Journal of the American College of Cardiology"},{"issue":"2","key":"ref34","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/eurheartj\/ehn534","article-title":"Patients with peripheral arterial disease in the CHARISMA trial","volume":"30","author":"PP Cacoub","year":"2009","journal-title":"European heart journal"},{"issue":"3","key":"ref35","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1365-2796.2006.01763.x","article-title":"Prevention of serious vascular events by aspirin amongst patients with peripheral arterial disease: randomized, double-blind trial","volume":"261","author":"M Catalano","year":"2007","journal-title":"Journal of internal medicine"},{"issue":"14","key":"ref36","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.jacc.2013.01.004","article-title":"Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF\/AHA Guideline Recommendations): a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"61","author":"TW Rooke","year":"2013","journal-title":"Journal of the American College of Cardiology"},{"issue":"2","key":"ref37","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ahj.2007.09.005","article-title":"Lower extremity peripheral arterial disease in individuals with coronary artery disease: prognostic importance, care gaps, and impact of therapy","volume":"155","author":"MJ Makowsky","year":"2008","journal-title":"American heart journal"},{"issue":"4","key":"ref38","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1001\/archinte.164.4.440","article-title":"Relationship between intermittent claudication, inflammation, thrombosis, and recurrent cardiac events among survivors of myocardial infarction","volume":"164","author":"CR Narins","year":"2004","journal-title":"Archives of internal medicine"},{"issue":"24","key":"ref39","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1161\/CIR.0b013e3181e3b133","article-title":"Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation","volume":"121","author":"M Pignone","year":"2010","journal-title":"Circulation"},{"issue":"1","key":"ref40","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ahj.2011.04.006","article-title":"Aspirin for the prevention of cardiovascular events in patients without clinical cardiovascular disease: a meta-analysis of randomized trials","volume":"162","author":"JS Berger","year":"2011","journal-title":"American heart journal"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0135692","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T00:33:22Z","timestamp":1748565202000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0135692"}},"subtitle":[],"editor":[{"given":"Hugo","family":"ten Cate","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,8,14]]},"references-count":40,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2015,8,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0135692","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,14]]}}}